These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23163069)

  • 1. Therapeutic effects of minoxidil high extra combination therapy in patients with androgenetic alopecia.
    Pazoki-Toroudi H; Babakoohi S; Nilforoushzadeh MA; Nassiri-Kashani M; Shizarpour M; Ajami M; Habibey R; Sadr B; Rashighi-Firoozabadi M; Firooz A
    Skinmed; 2012; 10(5):276-82. PubMed ID: 23163069
    [No Abstract]   [Full Text] [Related]  

  • 2. Alopecia in congenital hidrotic ectodermal dysplasia responding to treatment with a combination of topical minoxidil and tretinoin.
    Melkote S; Dhurat RS; Palav A; Jerajani HR
    Int J Dermatol; 2009 Feb; 48(2):184-5. PubMed ID: 19200200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is topical minoxidil solution effective on androgenetic alopecia in routine daily practice?
    Mapar MA; Omidian M
    J Dermatolog Treat; 2007; 18(5):268-70. PubMed ID: 17917938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy and tolerability of 5% minoxidil solution (Carexidil®) in male and female androgenetic alopecia: a 6-month open multicentric study].
    Piraccini B; Starace M; Alessandrini A; Guarrera M; Fiorucci MC; Lorenzi S
    G Ital Dermatol Venereol; 2011 Dec; 146(6 Suppl 1):1-8. PubMed ID: 22189834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.
    Shin HS; Won CH; Lee SH; Kwon OS; Kim KH; Eun HC
    Am J Clin Dermatol; 2007; 8(5):285-90. PubMed ID: 17902730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U; Kunte C; Krisp A; Garcia Bartels N; Ellwanger U; Hoffmann R
    J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
    Blume-Peytavi U; Issiakhem Z; Gautier S; Kottner J; Wigger-Alberti W; Fischer T; Hoffmann R; Tonner F; Bouroubi A; Voisard JJ
    J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical minoxidil therapy for androgenetic alopecia. A 30-month study.
    Koperski JA; Orenberg EK; Wilkinson DI
    Arch Dermatol; 1987 Nov; 123(11):1483-7. PubMed ID: 3314717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U; Hillmann K; Dietz E; Canfield D; Garcia Bartels N
    J Am Acad Dermatol; 2011 Dec; 65(6):1126-1134.e2. PubMed ID: 21700360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility and validity of minoxidil response testing in androgenetic alopecia.
    Goren A; Shapiro J; Roberts J; McCoy J; Desai N; Zarrab Z; Pietrzak A; Lotti T
    Dermatol Ther; 2015; 28(1):13-6. PubMed ID: 25112173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case series of oral minoxidil for androgenetic and traction alopecia: Tolerability & the five C's of oral therapy.
    Beach RA
    Dermatol Ther; 2018 Nov; 31(6):e12707. PubMed ID: 30246901
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse effects of low-dose oral minoxidil for androgenetic alopecia in 435 patients.
    Sanabria B; Vanzela TN; Miot HA; Müller Ramos P
    J Am Acad Dermatol; 2021 Apr; 84(4):1175-1178. PubMed ID: 33253848
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of minoxidil on hair growth in androgenic alopecia in women].
    Brzezińska-Wcisło L
    Pol Merkur Lekarski; 2002 Sep; 13(75):208-11. PubMed ID: 12474572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution.
    DeVillez RL; Jacobs JP; Szpunar CA; Warner ML
    Arch Dermatol; 1994 Mar; 130(3):303-7. PubMed ID: 8129407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
    Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
    Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.
    Tsuboi R; Tanaka T; Nishikawa T; Ueki R; Yamada H; Katsuoka K; Ogawa H; Takeda K
    Eur J Dermatol; 2007; 17(1):37-44. PubMed ID: 17324826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of minoxidil in the treatment of male and female androgenetic alopecia: a story of more than 30 years.
    Barbareschi M
    G Ital Dermatol Venereol; 2018 Feb; 153(1):102-106. PubMed ID: 29319278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical effect of JetpPeel-assisted topical minoxidil in the treatment of androgenetic alopecia: A randomized pilot study.
    Gong L; Bao L; Tian T; Li Y
    J Cosmet Laser Ther; 2018 Feb; 20(1):58-63. PubMed ID: 29166130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of androgenic alopecia with minoxidil].
    Kohl PK
    Hautarzt; 1993 Feb; 44(2):114. PubMed ID: 8449692
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomized trial of minoxidil in chemotherapy-induced alopecia.
    Duvic M; Lemak NA; Valero V; Hymes SR; Farmer KL; Hortobagyi GN; Trancik RJ; Bandstra BA; Compton LD
    J Am Acad Dermatol; 1996 Jul; 35(1):74-8. PubMed ID: 8682968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.